-+ 0.00%
-+ 0.00%
-+ 0.00%

Third Rock Ventures V disposes of Rapport Therapeutics common shares worth $743,673.08

PUBT·05/28/2026 20:16:45
Listen to the news
Third Rock Ventures V disposes of Rapport Therapeutics common shares worth $743,673.08
  • Third Rock Ventures V sold 18,572 shares of Rapport Therapeutics common stock on May 26, 2026.
  • Sale priced at a weighted average of USD 40.05 per share.
  • Direct holdings fell to 6,280,525 shares.
  • Third Rock Ventures VI reported 969,218 shares held indirectly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-245259), on May 28, 2026, and is solely responsible for the information contained therein.